Top Suppliers:I want be here





850-52-2

850-52-2 structure
850-52-2 structure
  • Name: Altrenogest
  • Chemical Name: Altrenogest
  • CAS Number: 850-52-2
  • Molecular Formula: C21H26O2
  • Molecular Weight: 310.430
  • Catalog: Biochemical Inhibitor Endocrinology & Hormones Estrogen/progestogen Receptor agonist
  • Create Date: 2018-05-20 08:00:00
  • Modify Date: 2025-08-20 12:35:41
  • Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.Target: Progesterone ReceptorAltrenogest is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with altrenogest appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. Altrenogest treatment also seems to be conductive to pregnancy maintenance in recipients experiencing luteal dysfunction [1]. The oil and gel altrenogest preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL [2].

Name Altrenogest
Synonyms (17b)-17-Hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one
13b-Methyl-17a-allyl-D4,9,11-gonatriene-17b-ol-3-one
(17β)-17-Hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one
Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propen-1-yl)-, (17β)-
Allyltrenbolone
r2267
17α-Allyl-17-hydroxyestra-4,9,11-trien-3-one
altregonest
(17β)-17-hydroxy-17-(prop-2-en-1-yl)estra-4,9,11-trien-3-one
Altrenogest
REGU-MATE
17-allyltrenbolone
ru2267
Estra-4,9,11-trien-3-one, 17-α-allyl-17-hydroxy-
(8S,13S,14S,17R)-17-Allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one
drc6246
Estra-4,9,11-trien-3-one, 17β-hydroxy-17-(2-propenyl)-
Regumate
17a-Allyl-17-hydroxyestra-4,9,11-trien-3-one
Description Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.Target: Progesterone ReceptorAltrenogest is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with altrenogest appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. Altrenogest treatment also seems to be conductive to pregnancy maintenance in recipients experiencing luteal dysfunction [1]. The oil and gel altrenogest preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL [2].
Related Catalog
References

[1]. Parry-Weeks, L.C. and D.W. Holtan, Effect of altrenogest on pregnancy maintenance in unsynchronized equine embryo recipients. J Reprod Fertil Suppl, 1987. 35: p. 433-8.

[2]. Daels, P.F., et al., Persistence of the luteal phase following ovulation during altrenogest treatment in mares. Theriogenology, 1996. 46(5): p. 799-811.

Density 1.1±0.1 g/cm3
Boiling Point 495.6±45.0 °C at 760 mmHg
Melting Point 120ºC
Molecular Formula C21H26O2
Molecular Weight 310.430
Flash Point 210.1±21.3 °C
Exact Mass 310.193268
PSA 37.30000
LogP 3.49
Vapour Pressure 0.0±2.9 mmHg at 25°C
Index of Refraction 1.594

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KG7745000
CHEMICAL NAME :
Estra-4,9,11-trien-3-one, 17-alpha-allyl-17-hydroxy-
CAS REGISTRY NUMBER :
850-52-2
LAST UPDATED :
199509
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H26-O2
MOLECULAR WEIGHT :
310.47
WISWESSER LINE NOTATION :
L E5 B666 OV AU CU MUTJ E1 FQ F2U1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 mg/kg
SEX/DURATION :
female 18 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
REFERENCE :
THGNBO Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1974- Volume(issue)/page/year: 16,195,1981
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
2500 ug/kg
SEX/DURATION :
female 10 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
REFERENCE :
JANSAG Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- Volume(issue)/page/year: 70,1357,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
810 ug/kg
SEX/DURATION :
female 15 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders Reproductive - Maternal Effects - other effects
REFERENCE :
JRFSAR Journal of Reproduction and Fertility, Supplement. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) No.1- 1966- Volume(issue)/page/year: 32,193,1982
WGK Germany 3.0
RTECS KG7745000
HS Code 2937290090
HS Code 2937290090
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.